Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Clal Biotechnology Climbs Most in Week on Alzheimer’s Drug Trial

Jan. 23 (Bloomberg) -- Clal Biotechnology Industries Ltd. advanced the most in a week after a unit’s Phase IIb trial of an Alzheimer’s drug showed intermediate “positive” results.

The shares of the investment company gained as much as 2.3 percent, the biggest intraday increase since Jan. 16, and were 1 percent higher at 21.10 shekels as of 11:24 a.m. in Tel Aviv.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.